Skip to main content
. 2023 Jun 29;12(3):445–471. doi: 10.1007/s40119-023-00323-8

Fig. 6.

Fig. 6

Current guideline recommendations for the management of heart failure. ARNI angiotensin receptor–neprilysin inhibitors, ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, MRA mineralocorticoid receptor antagonists, SGLT2i sodium glucose cotransporter-2 inhibitors, GDMT guideline-directed medical therapy, BB beta-blockers, RCT randomized controlled trial, ACCF/AHA/HFSA American Heart Association/American College of Cardiology/Heart Failure Society of America, ESC European Society of Cardiology